Postoperative morbidity associated with cesarean delivery among human immunodeficiency virus-seropositive women

被引:26
作者
Rodriguez, EJ [1 ]
Spann, C [1 ]
Jamieson, D [1 ]
Lindsay, M [1 ]
机构
[1] Emory Univ, Sch Med, Dept Gynecol & Obstet, Div Maternal Fetal Med, Atlanta, GA 30303 USA
关键词
cesarean delivery; human immunodeficiency virus; postoperative morbidity;
D O I
10.1067/mob.2001.115179
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: The aim of this study was to compare the complication rates associated with cesarean delivery between human immunodeficiency virus-seropositive women with those among a matched group of human immunodeficiency virus-seronegative subjects. STUDY DESIGN: We conducted a case-control study of 86 human immunodeficiency virus-seropositive women undergoing cesarean delivery between the years 1992 and 2000 at a large, urban teaching institution and a control group of 86 human immunodeficiency virus-seronegative women matched for age, race, year of delivery, and delivery indications. Data were analyzed with the chi (2) test and odds ratios. Among human immunodeficiency virus-seropositive women, complications were further stratified according to maternal disease status and use of antiretroviral therapy. RESULTS: Human immunodeficiency virus-seropositive women were significantly more likely than control women to have minor postoperative complications (66.3% vs 41.8%; odds ratio, 2.73; 95% confidence interval, 1.40-6.10), of which febrile morbidity was the most common (62.8% vs 42.7%; P = .003). There was no difference between the groups in the rate of major complications (9.3% vs 3.4%; odds ratio, 2.84; 95% confidence interval, 0.65-14.06). Zidovudine use was associated with a decrease in the maternal morbidity rate (odds ratio, 0.31; 95% confidence interval, 0.07-1.03). CONCLUSION: Postoperative morbidity among human immunodeficiency virus-seropositive women undergoing cesarean delivery was not different from that in a matched control population.
引用
收藏
页码:1108 / 1111
页数:4
相关论文
共 8 条
  • [1] The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1 -: A meta-analysis of 15 prospective cohort studies
    Andiman, W
    Boucher, M
    Burns, D
    Bryson, Y
    Farley, J
    Fowler, H
    Gabiano, C
    Galli, L
    Hutto, C
    Kind, C
    Korber, B
    Kovacs, A
    Krogstad, P
    Landesman, S
    Lapointe, N
    Lemay, M
    Lew, J
    Mandelbrot, L
    Mayaux, MJ
    Mellins, R
    Minkoff, H
    Mofenson, L
    Nielsen, K
    Newell, ML
    Pardi, G
    Peavy, H
    Peckham, C
    Read, J
    Rother, C
    Rudin, C
    Scott, G
    Semprini, A
    Shearer, W
    Simonds, R
    Simpson, B
    Stek, A
    Tovo, PA
    Tuomala, R
    Van Dyke, R
    Weedon, J
    de Martino, M
    Lindsay, M
    Belair, S
    Chan, L
    Harris, D
    Kalish, L
    Muenz, L
    Nugent, R
    Schluchter, M
    Durako, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (13) : 977 - 987
  • [2] Bulterys M, 1996, AIDS, V10, P923, DOI 10.1097/00002030-199607000-00019
  • [3] REDUCTION OF MATERNAL-INFANT TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH ZIDOVUDINE TREATMENT
    CONNOR, EM
    SPERLING, RS
    GELBER, R
    KISELEV, P
    SCOTT, G
    OSULLIVAN, MJ
    VANDYKE, R
    BEY, M
    SHEARER, W
    JACOBSON, RL
    JIMENEZ, E
    ONEILL, E
    BAZIN, B
    DELFRAISSY, JF
    CULNANE, M
    COOMBS, R
    ELKINS, M
    MOYE, J
    STRATTON, P
    BALSLEY, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (18) : 1173 - 1180
  • [4] Dean A.G, 1995, EPI INFO VERSION 6 W
  • [5] Complications after caesarean section in HIV-1-infected women not taking antiretroviral treatment
    Grubert, TA
    Reindell, D
    Kästner, R
    Lutz-Friedrich, R
    Belohradsky, BH
    Dathe, O
    [J]. LANCET, 1999, 354 (9190) : 1612 - 1613
  • [6] THE INCIDENCE OF COMPLICATIONS AFTER CESAREAN-SECTION IN 156 HIV-POSITIVE WOMEN
    SEMPRINI, AE
    CASTAGNA, C
    RAVIZZA, M
    FIORE, S
    SAVASI, V
    MUGGIASCA, ML
    GROSSI, E
    GUERRA, B
    TIBALDI, C
    SCARAVELLI, G
    PRATI, E
    PARDI, G
    [J]. AIDS, 1995, 9 (08) : 913 - 917
  • [7] Should women with human immunodeficiency virus be delivered by cesarean?
    Star, J
    Powrie, R
    Cu-Uvin, S
    Carpenter, CCJ
    [J]. OBSTETRICS AND GYNECOLOGY, 1999, 94 (05) : 799 - 801
  • [8] Prophylactic cesarean delivery for the prevention of perinatal human immunodeficiency virus transmission - The case for restraint
    Stringer, JSA
    Rouse, DJ
    Goldenberg, RL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (20): : 1946 - 1949